aspirin has been researched along with iloprost in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (18.33) | 18.7374 |
1990's | 26 (43.33) | 18.2507 |
2000's | 7 (11.67) | 29.6817 |
2010's | 12 (20.00) | 24.3611 |
2020's | 4 (6.67) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Basic-Micic, M; Breddin, HK; Herpel, U; Kling, E; Roman, C; Scholz, B | 1 |
Ansell, J; Cola, C | 1 |
Fiessinger, JN; Schäfer, M | 1 |
Addonizio, VP; Bell, P; Campbell, F; Ellison, N; Fisher, CA; Kappa, JR; Stenach, N; Todd, B | 1 |
Amerini, S; Ledda, F; Mantelli, L | 1 |
Lidbury, PS; Nathan, AW; Scriven, AJ | 1 |
Darnige, L; Delahousse, B; Gruel, Y; Guilmot, JL; Lang, M; Lermusiaux, P; Leroy, J; Rupin, A | 1 |
Addonizio, VP; Berkowitz, HD; Cottrell, ED; Fisher, CA; Kappa, JR | 1 |
Addonizio, VP; Berkowitz, HD; Cottrell, ED; Ellison, N; Fisher, CA; Kappa, JR; Sobel, M | 1 |
de Kam, J; Kort, WJ; Westbroek, DL | 1 |
Addonizio, VP; Cottrell, ED; Ellison, N; Fisher, CA; Horn, MK; Kappa, JR | 1 |
Barbenel, JC; Forbes, CD; Lowe, GD; Madhok, R; Saniabadi, AR; Shaw, B; Spowart, K | 1 |
Disa, J; Kowalska, MA; Rao, AK | 1 |
Stürzebecher, S; Witt, W | 1 |
Bekemeier, H; Hirschelmann, R | 1 |
Bertelé, V; de Gaetano, G; del Rosso, G; Libretti, A; Mussoni, L; Pintucci, G; Romano, G | 1 |
Hornberger, W; Patscheke, H | 1 |
Akar, F; Ercan, ZS; Türker, RK; Zengil, H | 1 |
Amore, C; Buczko, W; D'Adamo, MC; De Curtis, A; De Gaetano, G; Donati, MB; Iacoviello, L | 1 |
Dembińska-Kieć, A; Gryglewski, RJ; Peskar, BA; Stachura, J; Wenhrynowicz, O; Zmuda, A | 1 |
Hsu, P; Leffler, CW; Parfenova, H | 1 |
Kajiwara, Y; Quattrociocchi-Longe, T; Shanberge, JN | 1 |
Gryglewski, RJ; Swies, J | 1 |
Leffler, CW; Parfenova, H; Zuckerman, S | 1 |
Leffler, CW; Parfenova, H | 1 |
Li, SR; Pirker, W; Virgolini, I; Wandl, E; Yang, Q | 1 |
Grünberg, B; Kratzer, MA; Lorenz, R; Negrescu, EV; Siess, W | 1 |
Diehm, C; Stammler, F | 1 |
Arosio, E; Lechi, A; Minuz, P; Pancera, P; Ribul, M; Rossi, L | 1 |
Manchanda, SC; Maulik, M; Maulik, SK; Seth, SD | 1 |
Fligelstone, LJ; Horrocks, EH; Horrocks, M; Lane, IF; Murphy, P; Ruttley, MS; Watson, HR | 1 |
Khamashta, MA | 1 |
Ladjevardi, M; Wallén, NH | 1 |
Belcher, G; Horrocks, M; Watson, HR | 1 |
Ichikawa, A; Sugimoto, Y; Wang, J; Yamamoto, K; Yamamoto, S | 1 |
Hafner, J | 1 |
Gryglewski, RJ; Korbut, R; Starzyk, D | 1 |
Bambara, LM; Biasi, D; Caramaschi, P; Carletto, A; Volpe, A | 1 |
Adderley, SR; Cunningham, AJ; Dowd, NP; Fitzgerald, DJ; Scully, M | 1 |
Asadullah, K; Bauman, J; Colgan, SP; Fierro, IM; Giesen, C; Guilford, W; Parkinson, JF; Perez, HD; Schottelius, AJ | 1 |
Dörffler-Melly, J; Mahler, F; Schmidli, J | 1 |
Buerkle, MA; Conzen, P; Krötz, F; Lehrer, S; Pohl, U; Sohn, HY | 1 |
Berger, RM; Cromme-Dijkhuis, AH; Niggebrugge, M; Schoemaker, RG; van Albada, ME; van Veghel, R | 1 |
Cuccurullo, C; Davì, G; Di Iorio, P; Di Michele, D; Di Ruscio, P; Ferrante, E; Lattanzio, S; Laurora, G; Lessiani, G; Liani, R; Sgrò, G; Simeone, E; Vazzana, N | 1 |
Cauchy, E; Cheguillaume, B; Chetaille, E | 1 |
Bouchier-Hayes, D; Condron, C; Cunningham, AJ; Gang, C; Scully, M | 1 |
Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
Boyanova, D; Dandekar, T; Dittrich, M; Geiger, J; Hubertus, K; Mischnik, M; Philippi, N; Timmer, J; Wangorsch, G | 1 |
Metzler, C; Muehlenberg, K; Pech, O | 1 |
Baptista-Silva, JC; Cacione, DG; Macedo, CR | 2 |
Anastasiadou, C; Galyfos, G; Geropapas, G; Giannakakis, S; Kastrisios, G; Kerasidis, S; Maltezos, C; Papacharalampous, G; Papapetrou, A; Sachmpazidis, I | 1 |
Angelopoulos, G; Attal, R; Lazareth, I; Priollet, P | 1 |
Brodmann, M; Hafner, F; Jud, P | 1 |
Baptista-Silva, JC; Cacione, DG; do Carmo Novaes, F; Macedo, CR | 1 |
Davis, C; Lorentzen, AK; Penninga, L | 1 |
Senet, P | 1 |
Barnes, R; Imray, C; Lyons, T; Tam, A; Vennam, S | 1 |
9 review(s) available for aspirin and iloprost
Article | Year |
---|---|
Heparin-induced thrombocytopenia and arterial thrombosis: alternative therapies.
Topics: Aspirin; Cardiopulmonary Bypass; Chondroitin Sulfates; Dermatan Sulfate; Epoprostenol; Fibrinolytic Agents; Glycosaminoglycans; Heparin; Heparinoids; Heparitin Sulfate; Humans; Iloprost; Necrosis; Platelet Aggregation Inhibitors; Skin; Skin Diseases; Thrombocytopenia; Thrombosis | 1990 |
[Thromboangiitis obliterans (Buerger's syndrome): clinical aspects, diagnosis and therapy].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Aspirin; Calcium Channel Blockers; Diagnosis, Differential; Female; Humans; Iloprost; Male; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Prognosis; Risk Factors; Smoking; Sympathectomy; Thromboangiitis Obliterans | 1996 |
Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
Topics: Abortion, Habitual; Antibodies, Antiphospholipid; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Contraindications; Drug Therapy, Combination; Female; Heparin; Humans; Iloprost; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies; Recurrence; Thrombophilia; Thrombosis; Warfarin | 1998 |
Adjuvant medical therapy in peripheral bypass surgery.
Topics: Alprostadil; Anticoagulants; Aspirin; Chemotherapy, Adjuvant; Clinical Trials as Topic; Dextrans; Double-Blind Method; Femoral Artery; Heparin, Low-Molecular-Weight; Humans; Iloprost; Ischemia; Leg; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Randomized Controlled Trials as Topic; Ticlopidine; Vascular Surgical Procedures | 1999 |
Management of arterial leg ulcers and of combined (mixed) venous-arterial leg ulcers.
Topics: Alprostadil; Arterial Occlusive Diseases; Aspirin; Bandages; Electric Stimulation Therapy; Exercise Therapy; Humans; Iloprost; Infections; Leg Ulcer; Pain Management; Risk Factors; Spinal Cord; Vascular Surgical Procedures; Venous Insufficiency; Walking | 1999 |
Pharmacological treatment for Buerger's disease.
Topics: Alprostadil; Amputation, Surgical; Aspirin; Epoprostenol; Humans; Iloprost; Prostaglandins; Randomized Controlled Trials as Topic; Thromboangiitis Obliterans; Ulcer | 2016 |
Pharmacological treatment for Buerger's disease.
Topics: Adult; Alprostadil; Amputation, Surgical; Aspirin; Epoprostenol; Humans; Iloprost; Male; Middle Aged; Prostaglandins; Randomized Controlled Trials as Topic; Thromboangiitis Obliterans; Ulcer | 2016 |
Pharmacological treatment for Buerger's disease.
Topics: Adult; Alprostadil; Amputation, Surgical; Aspirin; Epoprostenol; Folic Acid; Hematinics; Humans; Iloprost; Male; Middle Aged; Pain; Placebos; Platelet Aggregation Inhibitors; Prostaglandins; Randomized Controlled Trials as Topic; Thromboangiitis Obliterans; Ulcer | 2020 |
Interventions for frostbite injuries.
Topics: Amputation, Surgical; Aspirin; Bias; Drug Therapy, Combination; Epoprostenol; Fibrinolytic Agents; Frostbite; Humans; Iloprost; Platelet Aggregation Inhibitors; Pyrrolidines; Recombinant Proteins; Rewarming; Tissue Plasminogen Activator; Vasodilator Agents | 2020 |
5 trial(s) available for aspirin and iloprost
Article | Year |
---|---|
Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
Topics: Adolescent; Adult; Amputation, Surgical; Anti-Arrhythmia Agents; Arm; Aspirin; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Epoprostenol; Follow-Up Studies; Humans; Iloprost; Ischemia; Leg; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Thromboangiitis Obliterans | 1990 |
The inhibitory effect of aspirin on fibrinolysis is reversed by iloprost, a prostacyclin analogue.
Topics: Adult; Antigens; Aspirin; Cardiovascular Agents; Epoprostenol; Fibrinolysis; Glycoproteins; Hemostasis; Humans; Iloprost; Male; Plasminogen Activators; Plasminogen Inactivators; Tissue Plasminogen Activator | 1989 |
The effects of platelet inhibitors on platelet uptake and restenosis after femoral angioplasty.
Topics: Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Constriction, Pathologic; Female; Femoral Artery; Humans; Iloprost; Indium Radioisotopes; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Popliteal Artery; Prospective Studies; Recurrence | 1997 |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Blood Platelets; CD40 Ligand; Chi-Square Distribution; Critical Illness; Dinoprost; Drug Administration Schedule; Female; Humans; Iloprost; Inflammation Mediators; Infusions, Intravenous; Ischemia; Italy; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Platelet Activation; Platelet Aggregation Inhibitors; Thromboxane B2; Time Factors; Treatment Outcome | 2011 |
A controlled trial of a prostacyclin and rt-PA in the treatment of severe frostbite.
Topics: Adult; Aspirin; Combined Modality Therapy; Drug Therapy, Combination; Female; Fibrinolytic Agents; Frostbite; Humans; Iloprost; Male; Platelet Aggregation Inhibitors; Pyrrolidines; Rewarming; Tissue Plasminogen Activator; Vasodilator Agents | 2011 |
46 other study(ies) available for aspirin and iloprost
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Platelet-induced thrombin generation time: a new sensitive global assay for platelet function and coagulation. Method and first results.
Topics: Adult; Aspirin; Blood Coagulation Disorders; Blood Coagulation Tests; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Middle Aged; Phenprocoumon; Platelet Aggregation; Platelet Function Tests; Reproducibility of Results; Sensitivity and Specificity; Thrombin; Time Factors | 1992 |
Intraoperative management of patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aspirin; beta-Thromboglobulin; Bleeding Time; Epoprostenol; Fibrinopeptide A; Heparin; Humans; Iloprost; Intraoperative Period; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Factor 4; Thrombocytopenia; Thromboxane B2 | 1990 |
Different effects of prostaglandins on adrenergic neurotransmission in atrial and ventricular preparations.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Dinoprostone; Electric Stimulation; Epoprostenol; Guinea Pigs; Heart; Heart Atria; Heart Ventricles; Iloprost; In Vitro Techniques; Indomethacin; Injections, Intraventricular; Prostaglandins; Sympathetic Nervous System; Synaptic Transmission | 1990 |
Effects of laser-generated tissue debris on aggregation of human platelets.
Topics: Aged; Angioplasty, Laser; Animals; Aorta; Aortic Diseases; Arteriosclerosis; Aspirin; Blood Coagulation; Heparin; Humans; Iloprost; In Vitro Techniques; Middle Aged; Platelet Aggregation; Swine; Thrombosis | 1991 |
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosis.
Topics: Aged; Aorta, Abdominal; Aspirin; Dipyridamole; Female; Femoral Vein; Heparin; Humans; Iliac Artery; Iliac Vein; Iloprost; Ischemia; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombocytopenia; Thrombosis; Vena Cava, Inferior | 1991 |
Heparin-induced platelet activation in sixteen surgical patients: diagnosis and management.
Topics: Adult; Aged; Aspirin; Epoprostenol; Female; Heparin; Humans; Iloprost; Male; Middle Aged; Platelet Aggregation; Platelet Count; Thrombocytopenia; Thrombosis | 1987 |
Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
Topics: Aged; Aspirin; beta-Thromboglobulin; Cardiovascular Agents; Carotid Arteries; Drug Evaluation; Endarterectomy; Epoprostenol; Fibrinopeptide A; Heparin; Humans; Iloprost; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Preoperative Care; Thrombosis | 1987 |
Per-operative topical administration of ZK 36 374 (Iloprost) acts favorably on patency of small artery anastomoses in rats.
Topics: Animals; Arteries; Aspirin; Epoprostenol; Female; Iloprost; Injections, Intra-Arterial; Intraoperative Period; Lidocaine; Microsurgery; Rats; Rats, Inbred BN; Vascular Patency | 1987 |
Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations.
Topics: Aged; Aspirin; Blood Platelets; Cardiac Surgical Procedures; Epoprostenol; Female; Heparin Antagonists; Humans; Iloprost | 1987 |
Red blood cells mediate spontaneous aggregation of platelets in whole blood.
Topics: 2-Chloroadenosine; Adenosine; Adult; Aged; Aspirin; Epoprostenol; Erythrocytes; Humans; Iloprost; In Vitro Techniques; Middle Aged; Platelet Aggregation; Platelet Count; Sulfonamides; Thrombosis | 1987 |
High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adenylyl Cyclases; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Calcium; Cyclic AMP; Deoxyadenosines; Dideoxyadenosine; Enzyme Induction; Epoprostenol; Humans; Iloprost; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Pyrazoles; Thromboxane B2 | 1988 |
The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine Diphosphate; Aspirin; Bridged Bicyclo Compounds, Heterocyclic; Collagen; Drug Synergism; Epoprostenol; Fatty Acids, Unsaturated; Humans; Hydrazines; Iloprost; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Prostaglandins, Synthetic; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides | 1988 |
Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
Topics: Aminopyrine; Animals; Aspirin; Benzydamine; Cardiovascular Agents; Carrageenan; Diclofenac; Epoprostenol; Female; Iloprost; Imidazoles; Phenylbutazone; Rats; Rats, Inbred Strains; Thrombosis; Thromboxanes; Trapidil | 1988 |
Hydrogen peroxide and methyl mercury are primary stimuli of eicosanoid release in human platelets.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Eicosanoids; Epoprostenol; Humans; Hydrogen Peroxide; Iloprost; Imidazoles; Indomethacin; Methylmercury Compounds; Platelet Aggregation; Serotonin; Thrombin | 1989 |
Possible prostacyclin-mediated vascular effect of angiotensin II in the isolated perfused rat lung.
Topics: Angiotensin I; Angiotensin II; Animals; Aspirin; Colon; Epoprostenol; Female; Iloprost; Lung; Lysine; Male; Nicotine; Pulmonary Circulation; Rats | 1983 |
Prostacyclin is required for t-PA release after venous occlusion.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Dose-Response Relationship, Drug; Fibrinolysis; Iloprost; Imidazoles; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred Strains; Thromboxane-A Synthase; Tissue Plasminogen Activator; Vena Cava, Inferior | 1994 |
Selectin-P-mediated adherence of platelets to neutrophils is regulated by prostanoids and nitric oxide.
Topics: Antigens, CD; Aspirin; Cell Adhesion Molecules; Humans; Iloprost; Male; Neutrophils; Nitric Oxide; P-Selectin; Platelet Adhesiveness; Platelet Membrane Glycoproteins | 1993 |
Dilator prostanoid-induced cyclic AMP formation and release by cerebral microvascular smooth muscle cells: inhibition by indomethacin.
Topics: 6-Ketoprostaglandin F1 alpha; Adenylyl Cyclases; Animals; Animals, Newborn; Aspirin; Brain; Cells, Cultured; Cyclic AMP; Cyclic GMP; Dinoprostone; Endothelium, Vascular; Enzyme Activation; Iloprost; In Vitro Techniques; Indomethacin; Microcirculation; Muscle, Smooth, Vascular; Receptors, Epoprostenol; Receptors, Prostaglandin; Signal Transduction; Swine | 1995 |
Effect of aspirin and iloprost on adhesion of platelets to intact endothelium in vivo.
Topics: Animals; Aspirin; Cricetinae; Endothelium, Vascular; Iloprost; Male; Mesocricetus; Platelet Adhesiveness; Protamines; Thrombin; Thrombosis | 1995 |
Streptokinase-prostacyclin--nitric oxide: in vivo interactions.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Cats; Epoprostenol; Extracorporeal Circulation; Fibrinolysis; Heparitin Sulfate; Iloprost; Infusions, Intravenous; Injections, Intravenous; Molsidomine; Nitric Oxide; Nitroarginine; Platelet Aggregation; Streptokinase; Thrombosis; Vasodilator Agents | 1995 |
Inhibitory effect of indomethacin on prostacyclin receptor-mediated cerebral vascular responses.
Topics: Animals; Animals, Newborn; Arterioles; Aspirin; Cerebrovascular Circulation; Hypercapnia; Iloprost; Indomethacin; Isoproterenol; Pia Mater; Receptors, Epoprostenol; Receptors, Prostaglandin; Swine | 1995 |
Functional study on vasodilator effects of prostaglandin E2 in the newborn pig cerebral circulation.
Topics: Animals; Animals, Newborn; Arterioles; Aspirin; Cerebral Cortex; Cerebrovascular Circulation; Cyclic AMP; Dinoprostone; Iloprost; Indomethacin; Receptors, Epoprostenol; Receptors, Prostaglandin; Swine; Vasodilator Agents | 1995 |
Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
Topics: Alprostadil; Aspirin; Carcinoma, Renal Cell; Cyclic AMP; Dinoprostone; Female; Humans; Iloprost; Kidney Neoplasms; Male; Middle Aged; Receptors, Drug; Receptors, Prostaglandin E; Tumor Cells, Cultured | 1993 |
Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
Topics: Adenosine Triphosphate; Aspirin; Blood Platelets; Cyclic AMP; Cyclic GMP; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Iodine Radioisotopes; Molsidomine; Nitric Oxide; Nitroprusside; Phosphorylation; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors | 1995 |
Postischemic hyperemia in subjects with lower limbs obstructive arteriopathy: role of PGI2 and endothelin.
Topics: Aged; Arteriosclerosis; Aspirin; Endothelins; Epoprostenol; Hemodynamics; Humans; Hyperemia; Iloprost; Ischemia; Leg; Middle Aged; Platelet Aggregation Inhibitors; Plethysmography; Regional Blood Flow; Vasodilator Agents | 1997 |
Lack of any additional benefit in combining aspirin with iloprost in a canine model of myocardial reperfusion injury.
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Disease Models, Animal; Dogs; Drug Synergism; Drug Therapy, Combination; Glycogen; Heart Rate; Iloprost; Lactic Acid; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Ventricular Pressure | 1997 |
Influence of low- and high-dose aspirin treatment on thrombin generation in whole blood.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Area Under Curve; Aspirin; Collagen; Dose-Response Relationship, Drug; Female; Humans; Iloprost; Immunoenzyme Techniques; Male; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Statistics, Nonparametric; Thrombin; Vasoconstrictor Agents | 1998 |
Induction of prostaglandin I(2) receptor by tumor necrosis factor alpha in osteoblastic MC3T3-E1 cells.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Northern; Cell Line; Cell Membrane; Dexamethasone; Iloprost; Mice; Nitrobenzenes; Osteoblasts; Receptors, Epoprostenol; Receptors, Prostaglandin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skull; Sulfonamides; Tumor Necrosis Factor-alpha | 1999 |
Effects of nitric oxide and prostacyclin on deformability and aggregability of red blood cells of rats ex vivo and in vitro.
Topics: Animals; Aspirin; Drug Interactions; Enzyme Inhibitors; Epoprostenol; Erythrocyte Aggregation; Erythrocyte Deformability; Iloprost; In Vitro Techniques; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation Inhibitors; Rats; Rats, Wistar | 1999 |
[Aspects of thrombophilia in Buerger's disease].
Topics: Adjuvants, Immunologic; Adult; Angiography; Aspirin; Female; Humans; Hyperhomocysteinemia; Iloprost; Male; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Smoking Cessation; Thromboangiitis Obliterans; Thrombophilia; Vasodilator Agents | 2000 |
Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Apoptosis; Arachidonic Acid; Aspirin; Biomarkers; Cardiomyopathies; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Doxorubicin; Enzyme Induction; Epoprostenol; Heart; Iloprost; Isoenzymes; L-Lactate Dehydrogenase; Male; Membrane Proteins; Myocardium; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Thromboxane B2; Transcription Factors; Troponin T | 2001 |
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcimycin; Cell Movement; Chemotaxis, Leukocyte; Croton Oil; Disease Models, Animal; Diterpenes; Female; Guinea Pigs; Humans; Hydroxyeicosatetraenoic Acids; Hypersensitivity, Delayed; Iloprost; Inflammation; Leukotriene B4; Lipoxins; Mice; Phthalic Anhydrides; Skin; Terpenes | 2002 |
[Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
Topics: Administration, Oral; Angioplasty, Balloon; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Blood Vessel Prosthesis; Clopidogrel; Confidence Intervals; Dipyridamole; Drug Therapy, Combination; Embolectomy; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intermittent Claudication; Leg; Meta-Analysis as Topic; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thrombectomy; Ticlopidine; Time Factors; Vitamin K | 2003 |
Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Arterioles; Aspirin; Cells, Cultured; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Endothelial Cells; Endothelium, Vascular; Humans; Iloprost; Membrane Proteins; Mesocricetus; Nitrobenzenes; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Skin Window Technique; Sulfonamides; Thrombophilia; Umbilical Veins | 2004 |
Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Pressure; Capillaries; Disease Models, Animal; Echocardiography; Gene Expression; Heart Ventricles; Hypertension, Pulmonary; Iloprost; Lung; Male; Myocardium; Organ Size; Platelet Aggregation Inhibitors; Pulmonary Artery; Pulmonary Circulation; Rats; Rats, Wistar; Receptors, Vascular Endothelial Growth Factor; Survival Rate; Vascular Endothelial Growth Factor A; Ventricular Remodeling | 2006 |
Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect.
Topics: Animals; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Iloprost; Lipoxins; Lung; Lung Injury; Male; Protective Agents; Pyrazoles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sulfonamides | 2012 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |
A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Hemorrhage; Humans; Iloprost; Integrins; Milrinone; Models, Biological; Molecular Dynamics Simulation; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Ticlopidine | 2013 |
[39-year-old man with 15 years lasting pain in both hands].
Topics: Administration, Oral; Adult; Aspirin; Chronic Pain; Diagnosis, Differential; Hand; Hematopoietic Stem Cell Transplantation; Humans; Iloprost; Infusions, Intravenous; Limb Salvage; Male; Smoking; Smoking Cessation; Thromboangiitis Obliterans | 2015 |
Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
Topics: Adult; Amputation, Surgical; Ankle Brachial Index; Anticoagulants; Arteritis; Aspirin; Cardiovascular Agents; Cilostazol; Critical Illness; Drug Therapy, Combination; Female; Heparin, Low-Molecular-Weight; Humans; Iloprost; Infusions, Intravenous; Ischemia; Limb Salvage; Lower Extremity; Male; Marijuana Abuse; Marijuana Smoking; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Smoking; Smoking Cessation; Tetrazoles; Thromboangiitis Obliterans; Time Factors; Treatment Outcome; Vasodilator Agents | 2017 |
Ranibizumab and digital ischemia.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Angioplasty; Aspirin; Combined Modality Therapy; Female; Fingers; Heparin, Low-Molecular-Weight; Humans; Iloprost; Intravitreal Injections; Ischemia; Macular Degeneration; Radial Artery; Ranibizumab; Rivaroxaban; Thrombectomy; Thrombosis; Ulnar Artery; Vascular Endothelial Growth Factor A | 2018 |
Frostbite of the hands after paragliding: a chilling experience.
Topics: Aspirin; Athletic Injuries; Betamethasone; Drug Therapy, Combination; Enoxaparin; Frostbite; Hand Injuries; Humans; Iloprost; Male; Treatment Outcome | 2019 |
[Paroxysmal vascular acrosyndromes: Practical approach to diagnosis and management].
Topics: Antibodies, Antinuclear; Aspirin; Calcium Channel Blockers; Erythromelalgia; Gabapentin; Humans; Iloprost; Lidocaine; Mexiletine; Raynaud Disease; Small Fiber Neuropathy; Sodium Channel Blockers | 2022 |
Early Use of Iloprost in Nonfreezing Cold Injury.
Topics: Aspirin; Cold Injury; Cold Temperature; Frostbite; Humans; Iloprost; Male; Microcirculation | 2022 |